Neurosterix
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $63M
Investors
- 3
About Neurosterix
Based in Geneva, Switzerland, and founded in 204, Neurosterix, a spinoff of Addex operates as a pharmaceutical research company dedicated to advancing the treatment of neurological disorders. The company by leveraging its drug discovery and development techniques, engages in the creation of allosteric modulators, which offer promising avenues for enhancing the efficacy and safety of neurological medications. Neurosterix's core focus lies in the identification and development of allosteric modulators, which exert their effects by binding to regulatory sites on target receptors. By modulating neurotransmission outside of traditional binding sites, these molecules offer potential advantages in terms of efficacy, safety, and tolerability. As of April 2024, the firm’s lead program is a muscarinic acetylcholine receptor subtype 4 positive allosteric modulator (M4 PAM) for the treatment of schizophrenia.
Who invested in Neurosterix
3 investors across 1 round
See all investors in Neurosterix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 2, 2024
Amount
$63M
Investors
Questions about Neurosterix
Who invested in Neurosterix?
Neurosterix has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurosterix raised?
Neurosterix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neurosterix last raise money?
Neurosterix's most recent round on record is a Series A, in Apr 2024.
What does Neurosterix do?
Based in Geneva, Switzerland, and founded in 204, Neurosterix, a spinoff of Addex operates as a pharmaceutical research company dedicated to advancing the treatment of neurological disorders.
Where is Neurosterix headquartered?
Neurosterix is headquartered in Geneva, Switzerland.
Which VCs invest in companies like Neurosterix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Neurosterix's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Neurosterix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.